BetterLungs® Immunity with IMMUSE™

Patented strain of Lactococcus lactis, a postbiotic that stimulates the body’s natural defenses by activating plasmacytoid dendritic cells (pDCs). These pDCs activate other immune cells, such as NK, killer-T, helper-T, and B cells, that play crucial roles in regular immune function. IMMUSE is backed by 27 studies, including 12 clinical trials comprised of 10 efficacy studies and two safety studies.*

In 2020, Dr. Chris pored over hundreds of scientific studies to find the best clinically supported ingredients that could support a healthy immune system, looking to expand the BetterLungs® lineup. When he learned about IMMUSE™ LC-Plasma, winner of the 2021 Frost & Sullivan North American Immune Health Ingredient and New Product Innovation Award, he saw its potential as a leading immune support ingredient. In fact, he believed in it so much that he decided to offer it as part of his pharmacist-approved line of Betterbrand products and the first respiratory gummy to leverage the ingredient!